NNMX — Nanomix Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $11.46m
- $0.02m
Annual income statement for Nanomix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.032 | 0.016 | 0.009 | 0.142 | 0.015 |
| Cost of Revenue | |||||
| Gross Profit | -0.035 | -0.011 | -0.023 | — | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3.31 | 3.88 | 0.795 | 8.25 | 8.45 |
| Operating Profit | -3.28 | -3.86 | -0.786 | -8.11 | -8.44 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.6 | -3.69 | -0.908 | -9.47 | -12.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.6 | -3.69 | -0.908 | -9.47 | -12.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.6 | -3.69 | -0.908 | -9.47 | -12.3 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.6 | -3.69 | -0.908 | -9.47 | -12.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.98 | -5.18 | -1.41 | -1.34 | -0.31 |